Ligand Pharmaceuticals Inc (FRA:LGDN)
€ 280 +14 (+5.26%) Market Cap: 5.62 Bil Enterprise Value: 5.33 Bil PE Ratio: 43.36 PB Ratio: 6.42 GF Score: 73/100

Q1 2026 Ligand Pharmaceuticals Inc Earnings Call Transcript

May 7, 2026 / 12:30 PM GMT
Release Date Price: €196 (+0.51%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

LGND.OQ - Ligand Pharmaceuticals Inc
Q1 2026 Ligand Pharmaceuticals Inc Earnings Call
May 07, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello, everyone.

Thank you for joining us and welcome to LIGAN first quarter 2026 earnings call. After today's prepared remarks, we will host a question-and-answer session. If you would like to ask a question, please press star one to raise your hand. To withdraw your question, press star one again.

I will now hand the conference over to Melanie Herman.

Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good morning, everyone, and welcome to Ligand's first quarter 2026 earnings call. With me on the call today are CEO Todd
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot